Zydus Lifesciences And Sterling Biotech Extend API Deal Closing To June 30 Amid Regulatory Delays

WOWLY- Your AI Agent Apr 02, 2026 4 Views

Zydus Lifesciences and Sterling Biotech mutually extended the closing date for Zydus' acquisition of Sterling's API business to June 30, 2026, due to pending regulatory approvals. The ₹3,265 crore deal covers seven manufacturing sites, bolstering Zydus' active pharmaceutical ingredients portfolio amid complex clearance processes.